FDAnews
www.fdanews.com/articles/137431-taro-domestic-business-to-boost-prospects

Taro, Domestic Business to Boost Prospects

June 7, 2011
Sun Pharma’s acquisition of Israel’s Taro Pharmaceutical Industries is finally paying off. The March quarter revenue of the Indian drugmaker rose 35.5 per cent year on year, to Rs 1,463.4 crore. Of this, Taro, which grew 21 per cent, contributed nearly Rs 480 crore.
Business Standard